Frecuencia del síndrome metabólico en mujeres posmenopáusicas según el índice de masa corporal y la relación cintura/cadera

1989, World Health Organization. The WHO MONICA Project: a world wide monitoring system for cardiovascular diseases. World Health Statitistical Annual Van der Graff, 1997, Menopause and cardiovascular disease, J Psychosom Obstet Gynecol, 18, 113, 10.3109/01674829709085577 Williams, 1997, Cardiovascular risk factors in women, Proc Nutr Soc, 56, 383, 10.1079/PNS19970040 Harris, 1993, Overweight, weight loss, and risk of coronary heart disease in older women. The NHANES I epidemiologic follow-up study, Am J Epidemiol, 137, 1318, 10.1093/oxfordjournals.aje.a116641 Zamboni, 1997, Effects of age on body fat distribution and cardiovascular risk factors in women, Am J Clin Nutr, 66, 111, 10.1093/ajcn/66.1.111 Bjorntorp, 1990, Portal adipose tissue as a generator of risk factors for cardiovascular disease and diabetes, Arteriosclerosis, 10, 493, 10.1161/01.ATV.10.4.493 Despres, 1990, Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease, Arteriosclerosis, 10, 497, 10.1161/01.ATV.10.4.497 Higgins, 1988, Hazzards of obesity - The Framingham experience, Acta Med Scand, 723, 23 Donahue, 1987, Central obesity in coronary heart disease in men, Lancet, 1, 821, 10.1016/S0140-6736(87)91605-9 Ducimetiere, 1986, The pattern of subcutaneous fat distribution in middle-aged men and the risk of coronary heart disease. The Paris Prospective Study, Int J Obes, 10, 229 Ferranini, 1995, Physiological and metabolic consequences of obesity, Metabolism, 44, 15, 10.1016/0026-0495(95)90313-5 Ludvik, 1995, Effect of obesity on insulin resistance in normal subjects and patients with NIDDM, Diabetes, 44, 1121, 10.2337/diabetes.44.9.1121 Despres, 1994, Relation of components of insulin resistance syndrome to coronary disease risk, jCurr Opin Lipidol, 5, 274, 10.1097/00041433-199408000-00006 Olefsky, 1988, Cellular mechanisms of insulin resistance to non-insulin-dependent (type II) diabetes, Am J Med, 85, 86, 10.1016/0002-9343(88)90401-9 Camus, 1966, Goutte, diabete, hyperlipemie: un trisyndrome metabolique, Rev Rheumat, 33, 10 Reaven, 1988, Role of insulin resistance in human disease, Diabetes, 37, 1595, 10.2337/diabetes.37.12.1595 Modan, 1985, Hyperinsulinemia: a link between hypertension, obesity and glucose intolerance, J Clin Invest, 75, 809, 10.1172/JCI111776 Kaplan, 1989, The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension, Arch Intern Med, 149, 1514, 10.1001/archinte.1989.00390070054005 Despres, 1997, The insulin resistant-dyslipidemic syndrome of visceral obesity: An atherogenic cluster, 10.1016/S0021-9150(97)89505-6 Pyorala, 1979, Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two populations studies in Finland, Diabetes Care, 2, 131, 10.2337/diacare.2.2.131 Ducimetiere, 1980, Relationship of plasma insulin level to the incidence of myocardial infarction and coronary heart disease mortality in middle-aged population, Diabetologia, 19, 205, 10.1007/BF00275270 Després, 1996, Hyperinsulinemia as an independent risk factor for ischemic heart disease, N Engl J Med, 334, 952, 10.1056/NEJM199604113341504 Laakso, 1996, Insulin resistance and coronary heart disease, Curr Opin Lipidol, 7, 217, 10.1097/00041433-199608000-00008 Kvist, 1988, Predictive equations of total and visceral adipose tissue volumes derived from measurements with computed tomography in adult men and women, Am J Clin Nutr, 48, 1351, 10.1093/ajcn/48.6.1351 Valdez, 1993, A new index of abdominal adiposity as an indicator of risk for cardiovascular disease. A cross-population study, Intern J Obesity, 17, 77 Coniglio, 1992, Prevalencia de los factores de riesgo para las enfermedades cardiovasculares en zonas urbanas de la Patagonia Argentina. Estudio multicéntrico, Medicina (Buenos Aires, 52, 320 Bjorntorp, 1985, Regional patterns of fat distribution, Ann Intern Med, 103, 994, 10.7326/0003-4819-103-6-994 1988, Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure, Arch Intern Med, 148, 1023, 10.1001/archinte.1988.00380050029006 Coniglio, 1983, Determinación de apolipoproteína B por electroinmunodifusión en pacientes normo e hipercolesterolémicos, Acta Bioquim Clin Lat, 17, 401 Friedewald, 1972, Estimation of concentration of low density lipoprotein cholesterol in plasma without use of the ultracentrifugation, Clin Chem, 18, 449, 10.1093/clinchem/18.6.499 Matthews, 1985, Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man, Diabetologia, 28, 412, 10.1007/BF00280883 Lindahl, 1996, Insulin-resistance syndrome and fibrinolytic activity: the Northern Sweden MONICA Study, Intern J Epidemiol, 25, 291, 10.1093/ije/25.2.291 Bergman, 1985, Assessment of insulin sensitivity in vivo, Endocrine Rev, 6, 45, 10.1210/edrv-6-1-45 Laakso, 1993, How good a marker is insulin level for insulin resistance?, Am J Epidemiol, 137, 959, 10.1093/oxfordjournals.aje.a116768 Coniglio, 1997, Obesidad central: relación entre el índice de conicidad y los factores de riesgo lipoproteicos para la aterosclerosis coronaria, Medicina (Buenos Aires, 57, 21 Welborn, 1966, Serum insulin in essential hypertension and peripheral vascular disease, Lancet, 1, 1336, 10.1016/S0140-6736(66)92132-5 Modan, 1985, Hyperinsulinemia: a link between hypertension, obesity and glucose intolerance, J Clin Invest, 75, 809, 10.1172/JCI111776 Haffner, 1992, Prospective analysis of the insulin resistance syndrome (syndrome X, Diabetes, 41, 715, 10.2337/diabetes.41.6.715 Lucas, 1985, Insulin and blood pressure in obesity, Hypertension, 7, 702, 10.1161/01.HYP.7.5.702 Fournier, 1986, Blood pressure, insulin, and glycemia in nondiabetic subjetcs, Am J Med, 80, 861, 10.1016/0002-9343(86)90629-7 Ferranini, 1997, Insulin resistance, hyperinsulinemia and blood pressure. Role of age and obesity, Hypertension, 30, 1144, 10.1161/01.HYP.30.5.1144 De Fronzo, 1981, The effect of insulin on renal sodium metabolism: a review with clinical implications, Diabetologia, 21, 165 Rowe, 1981, Effect of insulin and glucose infusions of sympathetic nervous system activity in normal man, Diabetes, 30, 219, 10.2337/diab.30.3.219 Daly, 1991, Hypertension in obesity and NIDDM: role of insulin and sympathetic nervous system, Diabetes Care, 14, 240, 10.2337/diacare.14.3.240 Stout, 1990, Insulin and atheroma: 20 years perspective, Diabetes Care, 13, 631, 10.2337/diacare.13.6.631 Resnik, 1993, Ionic basis of hypertension, insulin resistance, vascular disease and related disorders. The mechanism of “Syndrome X”, Am J Hypertens, 126, 924 Zavaroni, 1994, Hyperinsulinemia, obesity and syndrome X, J Intern Med, 235, 51, 10.1111/j.1365-2796.1994.tb01031.x Després, 1994, Dyslipemia and obesity, Bailliere’s Clin Endocrinol Metab, 4, 629, 10.1016/S0950-351X(05)80289-7 Manninen, 1992, Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment, Circulation, 85, 37, 10.1161/01.CIR.85.1.37 Assman, 1992, Relation of high density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary heart disease (The PROCAM Experience, Am J Cardiol, 70, 733, 10.1016/0002-9149(92)90550-I Austin, 1998, Hypertriglyceridemia as a cardiovascular risk factor, Am J Cardiol, 81, 7, 10.1016/S0002-9149(98)00031-9 Coniglio, 1995, La hipertrigliceridemia como factor de riesgo para la aterosclerosis coronaria, Acta Bioquim Clin Lat, 29, 129 Austin, 1995, LDL subclass phenotypes and the risk factors of the insulin resistance syndrome, Int J Obes, 19, 22 Nordestgaard, 1996, The vascular endothelial barrier - Selective retention of lipoproteins, Curr Opin Lipidol, 7, 269, 10.1097/00041433-199610000-00002 De Graff, 1991, Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects, Arterioscler Thromb, 11, 298, 10.1161/01.ATV.11.2.298 Austin, 1988, Low density lipoprotein subclass pattern and risk of myocardial infarction, JAMA, 260, 1917, 10.1001/jama.1988.03410130125037 Sniderman, 1980, Association of coronary atherosclerosis with hyperapobetalipoproteinemia (increased protein but normal cholesterol levels in human plasma low density (beta lipoproteins, Proc Natl Acad Sci USA, 77, 604, 10.1073/pnas.77.1.604 Myer, 1968, The relationship of serum uric acid to risk factors in coronary heart disease, Am J Med, 45, 420 Facchini, 1991, Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid cleareance, and plasma uric acid concentration, JAMA, 266, 3008, 10.1001/jama.1991.03470210076036